Department of Neurosurgery, Iwate Medical University, Japan.
Institute for Biomedical Sciences, Iwate Medical University, Japan.
J Stroke Cerebrovasc Dis. 2022 Aug;31(8):106588. doi: 10.1016/j.jstrokecerebrovasdis.2022.106588. Epub 2022 Jun 4.
Although revascularization surgery is recommended for adult patients with moyamoya disease (MMD) who present with ischemic symptoms due to hemodynamic compromise, the clinical course of such patients who are treated with medical management alone remains unclear. Here, we report outcomes of adult patients with cerebral misery perfusion due to ischemic MMD who received medical management alone.
We prospectively followed up patients who showed misery perfusion in the symptomatic cerebral hemisphere on O gas positron emission tomography (PET) and received strict medical management alone after refusing revascularization surgery.
Of 57 patients who showed symptomatic misery perfusion on O gas PET, three (5%) were included into the present study. Two of these patients suffered further ischemic events at 7 and 8 months after inclusion, after which, their modified Rankin disability scale scores deteriorated. In the remaining patient, fatal intracerebral hemorrhage developed at 10 months after inclusion.
These findings suggest that receiving medical management alone is associated with considerably poor outcomes for adult patients with cerebral misery perfusion due to ischemic MMD.
尽管血运重建手术被推荐用于因血流动力学障碍而出现缺血症状的成人烟雾病(MMD)患者,但单独接受药物治疗的此类患者的临床病程尚不清楚。在此,我们报告了单独接受药物治疗的因缺血性 MMD 导致脑低灌注的成年患者的结局。
我们前瞻性随访了在 O 气体正电子发射断层扫描(PET)上显示症状性大脑半球低灌注且在拒绝血运重建手术后仅接受严格药物治疗的患者。
在 57 例在 O 气体 PET 上显示有症状性低灌注的患者中,有 3 例(5%)被纳入本研究。这 2 例患者在纳入后 7 个月和 8 个月时再次发生缺血性事件,此后其改良 Rankin 残疾量表评分恶化。在其余患者中,纳入后 10 个月发生致命性颅内出血。
这些发现表明,对于因缺血性 MMD 导致脑低灌注的成年患者,单独接受药物治疗与相当差的结局相关。